| http://dbpedia.org/ontology/abstract
|
Cyriac Roeding (born March 26, 1973) is a … Cyriac Roeding (born March 26, 1973) is a Silicon Valley-based German-American entrepreneur and investor. He serves as the co-founder and CEO of Earli, an early cancer detection and treatment firm based in Redwood City, California. Earli is based on Synthetic Biopsy technology from Stanford University, and is funded by Andreessen Horowitz, Khosla Ventures, Perceptive Advisors, Casdin Capital, Sands Capital, Menlo Ventures, ZhenFund (China) and Marc Benioff. Roeding is also a co-founder and chairman of the board of Rewind Co., a diabetes type 2 reversal company. Roeding's venture investing focuses on consumer businesses, biology meeting software and engineering, brain-to-machine interfaces, AI and consumer robotics. He served as EVP at Paramount Global / CBS (NASDAQ: PARA), where he started the division CBS Mobile, and as an entrepreneur-in-residence at Kleiner Perkins and its iFund with Apple Inc., where he co-founded and led mobile shopping app shopkick to 20 million users and a $250M cash acquisition by SK Telecom/SK Planet (Fortune 100 from South Korea). Shopkick rewards users for just walking into retail stores such as Target Corporation, Best Buy, Macy's and Walmart and engaging with products from Procter & Gamble, Pepsi, L'Oreal etc., driving over $1B in sales annually for its partners. Fast Company ranked shopkick one of the world's 10 Most Innovative Companies In Retail, alongside Apple and Starbucks, and Entrepreneur Magazine placed Roeding on its cover. The World Economic Forum named Roeding a Tech Pioneer in 2013 and a Global Innovator in 2021. Roeding is a Limited Partner in venture capital funds Andreessen Horowitz, Founders Fund, Bond (Mary Meeker), Tiger Global Management, Coatue Management, Greylock Partners, KPCB, IVP, Atomic VC, ZhenFund (China), Breakthrough Ventures, Olive Capital, Script Capital, Silicon Valley Bank. He is a direct investor and advisor in over a dozen startups, including LTSE (Long-Term Stock Exchange), Synthego (CRISPR genome editing), Science Inc. (brain-to-machine interfaces), Karma Science (acquired by Facebook), Cardspring (acquired by Twitter), Visby Medical, Cars24 (used car sales platform in India), Grofers (e-groceries in India), Curbside (acquired by Rakuten), Zumper, Brilliant (intelligent home light switches). He is frequently included on innovation topics such as Chinese vs Silicon Valley startups on CNBC, Bloomberg, CNN, has published on these topics e.g. on Vox/Recode, and has been a speaker at the World Economic Forum in Davos, at Stanford's Entrepreneurial Thought Leaders Program, the CTIA Wireless Summit and Money 2020., the CTIA Wireless Summit and Money 2020.
|
| rdfs:comment |
Cyriac Roeding (born March 26, 1973) is a … Cyriac Roeding (born March 26, 1973) is a Silicon Valley-based German-American entrepreneur and investor. He serves as the co-founder and CEO of Earli, an early cancer detection and treatment firm based in Redwood City, California. Earli is based on Synthetic Biopsy technology from Stanford University, and is funded by Andreessen Horowitz, Khosla Ventures, Perceptive Advisors, Casdin Capital, Sands Capital, Menlo Ventures, ZhenFund (China) and Marc Benioff. Roeding is also a co-founder and chairman of the board of Rewind Co., a diabetes type 2 reversal company. Roeding's venture investing focuses on consumer businesses, biology meeting software and engineering, brain-to-machine interfaces, AI and consumer robotics. He served as EVP at Paramount Global / CBS (NASDAQ: PARA), where he startedbal / CBS (NASDAQ: PARA), where he started
|
